State Ledger
Company profile

Q/C TECHNOLOGIES, INC. CIK 1321834

Ticker
QCLS (Nasdaq)
Industry
In Vitro & In Vivo Diagnostic Substances
Headquarters
New York, NY 10036
Fiscal year end
2025 (FY)
Market Data
Close
$0.58
Change
-$0.02
Change %
-3.94%
Volume
500

QCLS · trading date Oct 12, 2026 · previous close $0.61 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$11.63M
Total assets
$41.17M
Total liabilities
$16.44M
Stockholders' equity
$21.75M
Cash & equivalents
$987.0K
Operating income
-$9.85M
Operating cash flow
-$9.07M
Capital expenditures
$1.75M

Fiscal year 2025, via 10-K filed 2026-04-15. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$10.82M
Free cash flow margin
—
Liabilities / assets
39.9%
Equity / assets
52.8%
CapEx / revenue
—
Operating cash flow / net income
0.78×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$11.63M $41.17M $16.44M $21.75M
2024 — -$23.36M $21.42M $6.70M $9.79M
2023 — -$4.00M $17.86M $5.09M $12.37M
2022 — -$15.20M $17.54M $2.84M $14.70M
2021 — -$29.89M $24.81M $1.17M $23.65M
Company Details
SIC code
2835
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-09-18
Financials filed via
Form 10-K
filed 2026-04-15

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
New York, NY 10036
1185 AVENUE OF THE AMERICAS
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:43 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to New York — Public Companies